Volume 2 Supplement 1

ESICM LIVES 2014

Open Access

0329. Beneficial effects of azithromycin combined with ceftazidime without activity against P. aeruginosa in a murine sepsis model of peritonitis by Pseudomonas aeruginosa

  • ME Pachón-Ibañez1,
  • A Díaz-Martín2,
  • J Dominguez-Herrera1,
  • G Labrador1,
  • Y Smani1,
  • J Pachón1 and
  • J Garnacho-Montero2
Intensive Care Medicine Experimental20142(Suppl 1):P18

DOI: 10.1186/2197-425X-2-S1-P18

Published: 26 September 2014

Introduction

Despite a proper management, the mortality of patients with severe sepsis and septic shock is very high. During sepsis, an uncontrolled cascade of inflammatory mediators is triggered, leading to tissue damage that can cause death. Macrolides, apart from their antibiotic properties, are capable of modulating inflammatory response. Macrolides inhibit the production and secretion of pro-inflammatory cytokines (IL-1, IL-6, IL-8 and TNF-α) levels and increase anti-inflammatory cytokines such as IL-10.

Objectives

To demonstrate whether the use of azithromycin (AZM) in a murine sepsis model of P. aeruginosa increases ceftazidime (CFZ) efficacy.

Methods

MIC/MBC and bactericidal activity (time-killed curves using 1MIC) were performed using four clinical isolates of P. aeruginosa. The bactericidal activity on Pa4, chosen for the in vivo study, was carried out too at the maximum plasma concentration (Cmax) in mice. Pharmacokinetic/pharmacodynamic (PK/PD) parameters of CFZ and AZM were calculated (HPLC-MS/MS). The activity of each antimicrobial agent and its combination was assessed in a murine peritonitis model (n=15), using the minimum lethal dose (MLD) of Pa4 as inoculum. Treatment were: 100 mg/kg/ip/12h for CFZ and 30 mg/kg/ip/24h for AZM, during 72 hours; a group of 15 untreated mice were used as control (CON). CFU/g spleen, mortality and blood cultures were compared.

Results

The MIC/MBC (mg/L) ranges of CFZ were 2-4/2-32 and for AZM 64/128->128. In time-kill curves no bactericidal activity was observed with any of the strains at concentration of 1MIC. At concentration of Cmax, CFZ+AZM reached bactericidal activity, but not synergy was found. PK/PD results are shown in table 1. In the animal model (table 2), CFZ and CFZ+AZM were better than CON and AZM, and the combination better than the CFZ and AZM (p< 0.001, ANOVA, post hoc tests) respect to the CFU/g spleen and the blood cultures. No differences were found in the mortality rates (chi-square test). In the survival analysis, CFZ+AZM delayed the mortality compared with the other groups (p< 0.001, Kaplan-Meier).
Table 1

PK/PD results

  

CFZ

AZM

PK

Cmax (µg/mL)

107.14

4.57

PK

Tmax (h)

1.08

2.14

PK

AUC0-∞ (µg*h/L)

126.83

3.81

PD

Cmax/MIC

107.14

0.07

PD

T1/2/MIC

1.08

0.02

PD

AUC0-∞/MIC

126.83

1.98

Table 2

In vivo studies

 

CON

CFZ

AZM

CFZ+AZM

Log UFC/g Spleen (Mean ± SD)

8.40 ± 0.32

6.57 ± 0.61

7.58 ± 0.31

4.63 ± 0.77

Positive blood culture (%)

100

47

100

0

Exitus (%)

100

100

100

100

Conclusions

The combination of AZM with CFZ increases bacterial clearance from spleen and blood and delays the time to mortality in a murine sepsis model by P. aeruginosa.

Declarations

Grant acknowledgment

This project (PI10/01563) was funded by the "Fondo de Investigación Sanitaria", Instituto de Salud Carlos III.

Authors’ Affiliations

(1)
UCEIMP/IBIS-University Hospital Virgen del Rocío, University of Seville
(2)
University Hospital Virgen del Rocio, Intensive Care Unit

Copyright

© Pachón-Ibañez et al; licensee Springer. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement